Allergic rhinitis is the most common chronic childhood disease. Reduced quality of life is frequently caused by this IgE-mediated disease, including sleep disturbance with subsequent decreased school performance. Asthma and exercise-induced bronchospasm are commonly seen concurrently with allergic rhinitis, and poorly controlled allergic rhinitis negatively affects asthma outcomes. Nonsedating antihistamines or intranasal azelastine are effective agents to manage allergic rhinitis, often in combination with oral decongestants. For moderate to severe persistent disease, intranasal corticosteroids are the most effiective agents. Some patients require concomitant intranasal corticosteroids and nonsedating antihistamines for optimal management. Other available agents include leukotriene receptor antagonists, intranasal cromolyn, intranasal ipratropium, specific immunotherapy, and anti-IgE therapy.
Management of Allergic Rhinitis
Verra O. Sausen, Katherine E. Marks, Kenneth P. Sausen, Timothy H. Self; Management of Allergic Rhinitis. The Journal of Pediatric Pharmacology and Therapeutics 1 July 2005; 10 (3): 159–173. doi: https://doi.org/10.5863/1551-6776-10.3.159
Download citation file: